If you're in Luxembourg this coming Thursday, 12 May, and have nothing better to do, why not pop into the Court of Justice of the European Union and check out the hearing in Joined Cases C-322/10 and C-422/10 Medeva and Georgetown University and Others.
Just to remind you, these are references for a preliminary ruling from the Court of Appeal (England and Wales) on the interpretation of Articles 3(a) and (b) of Regulation 469/2009 regarding the meaning of ‘product protected by a basic patent in force’ and whether there exist further or different criteria in respect of a medicinal product comprising more than one active ingredient or for a multi-disease vaccine.
Opinion of AG Trstenjak annouced for July 2011
ReplyDeleteOpinion AG Trstenjak 13/07/2011
ReplyDelete